Nautilus Biotechnology
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2016
- Employees
- 150
- Stage
- Public
- Total raised
- $200M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $200M · Jun 2021 SEC Form D
- Founders
- Sujal Patel, Parag Mallick, PhD
Nautilus Biotechnology hires ex-Smartsheet, Isilon and GenapSys leaders as it scales proteome platform after $76M Series B
Nautilus Biotechnology, a stealthy startup co-founded by Sujal Patel and Parag Mallick, has hired three senior executives — Chris Blessington, Anna Mowry, and Subra Sankar — to expand its team and accelerate development of a platform to quantify the human proteome after a $76 million Series B.
Amazon names Anne Toth director of Alexa Trust; Zillow adds Claire Cormier Thielke to board; Lockstep exits stealth
Amazon hired Anne Toth as director of Alexa Trust to lead privacy, security, accessibility and ethics efforts for Alexa; Zillow added Claire Cormier Thielke to its board and Lockstep, a Seattle accounting-software startup founded in 2019, emerged from stealth with a founding team drawn from Avalara, Globys, e2b Teknologies and Winshuttle.
Athira Pharma raises $85M Series B to push NDX-1017 toward FDA approval for Alzheimer’s, Parkinson’s and ALS
Seattle biotech Athira Pharma raised $85 million in a Series B round to advance NDX-1017, a regenerative therapy aimed at halting or reversing nerve damage in Alzheimer’s, Parkinson’s and ALS, with preliminary trial results reported as positive and potential market availability in 2–3 years.
Nautilus Biotechnology raises $76M Series B led by Vulcan Capital; Bezos Expeditions among investors, total funding tops $100M
Nautilus Biotechnology, co-founded by Stanford scientist Parag Mallick and Isilon co-founder Sujal Patel, revealed a platform to study the human proteome and announced a $76 million Series B led by Vulcan Capital with participation from Bezos Expeditions, Perceptive Advisors and others. The round brings total funding above $100 million for the 50-person startup as it exits stealth to accelerate proteomics-driven therapeutics development.
People
-
Sujal Patel Executive, Co-founder and CEO, Executive Officer, Director
